Susquehanna International Group’s Teladoc Health TDOC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $4.83M | Sell |
885,526
-175,942
| -17% | -$987K | ﹤0.01% | 4299 |
|
|
2025
Q4 | $7.43M | Sell |
1,061,468
-449,643
| -30% | -$3.52M | ﹤0.01% | 3451 |
|
|
2025
Q3 | $11.7M | Sell |
1,511,111
-535,162
| -26% | -$4.18M | ﹤0.01% | 2851 |
|
|
2025
Q2 | $17.8M | Buy |
2,046,273
+1,292,854
| +172% | +$9.37M | ﹤0.01% | 2125 |
|
|
2025
Q1 | $6M | Sell |
753,419
-188,944
| -20% | -$1.91M | ﹤0.01% | 3313 |
|
|
2024
Q4 | $8.57M | Buy |
942,363
+571,552
| +154% | +$5.52M | ﹤0.01% | 2848 |
|
|
2024
Q3 | $3.4M | Sell |
370,811
-1,731,303
| -82% | -$14.3M | ﹤0.01% | 4320 |
|
|
2024
Q2 | $20.6M | Buy |
2,102,114
+1,389,716
| +195% | +$17M | ﹤0.01% | 1695 |
|
|
2024
Q1 | $10.8M | Sell |
712,398
-985,065
| -58% | -$17.9M | ﹤0.01% | 2509 |
|
|
2023
Q4 | $36.6M | Buy |
1,697,463
+859,001
| +102% | +$15.8M | 0.01% | 1267 |
|
|
2023
Q3 | $15.6M | Buy |
838,462
+233,683
| +39% | +$5.45M | ﹤0.01% | 2036 |
|
|
2023
Q2 | $15.3M | Buy |
604,779
+189,727
| +46% | +$4.78M | ﹤0.01% | 2001 |
|
|
2023
Q1 | $10.7M | Buy |
415,052
+63,095
| +18% | +$1.69M | ﹤0.01% | 2347 |
|
|
2022
Q4 | $8.32M | Buy |
351,957
+279,728
| +387% | +$7.54M | ﹤0.01% | 2505 |
|
|
2022
Q3 | $1.83M | Sell |
72,229
-618,768
| -90% | -$21.7M | ﹤0.01% | 5095 |
|
|
2022
Q2 | $22.9M | Buy |
690,997
+206,828
| +43% | +$8.78M | 0.01% | 1342 |
|
|
2022
Q1 | $34.9M | Sell |
484,169
-214,102
| -31% | -$15.4M | 0.01% | 1231 |
|
|
2021
Q4 | $64.1M | Sell |
698,271
-229,598
| -25% | -$27.4M | 0.01% | 950 |
|
|
2021
Q3 | $118M | Sell |
927,869
-150,542
| -14% | -$21.9M | 0.02% | 712 |
|
|
2021
Q2 | $179M | Sell |
1,078,411
-246,070
| -19% | -$39.9M | 0.03% | 544 |
|
|
2021
Q1 | $241M | Buy |
1,324,481
+501,847
| +61% | +$116M | 0.04% | 387 |
|
|
2020
Q4 | $164M | Buy |
822,634
+290,329
| +55% | +$59M | 0.03% | 479 |
|
|
2020
Q3 | $117M | Buy |
532,305
+91,928
| +21% | +$19.5M | 0.02% | 515 |
|
|
2020
Q2 | $84M | Buy |
440,377
+117,175
| +36% | +$20.5M | 0.02% | 575 |
|
|
2020
Q1 | $50.1M | Buy |
323,202
+184,769
| +133% | +$21.5M | 0.02% | 655 |
|
|
2019
Q4 | $11.6M | Buy |
138,433
+104,866
| +312% | +$7.98M | ﹤0.01% | 1928 |
|
|
2019
Q3 | $2.27M | Buy |
33,567
+1,580
| +5% | +$104K | ﹤0.01% | 3946 |
|
|
2019
Q2 | $2.12M | Sell |
31,987
-120,268
| -79% | -$7.01M | ﹤0.01% | 4060 |
|
|
2019
Q1 | $8.46M | Sell |
152,255
-46,456
| -23% | -$2.84M | ﹤0.01% | 1899 |
|
|
2018
Q4 | $9.85M | Sell |
198,711
-42,399
| -18% | -$2.59M | ﹤0.01% | 1616 |
|
|
2018
Q3 | $20.8M | Buy |
241,110
+158,537
| +192% | +$11.3M | 0.01% | 1302 |
|
|
2018
Q2 | $4.79M | Sell |
82,573
-32,865
| -28% | -$1.61M | ﹤0.01% | 2761 |
|
|
2018
Q1 | $4.65M | Buy |
115,438
+101,367
| +720% | +$3.83M | ﹤0.01% | 2628 |
|
|
2017
Q4 | $490K | Buy |
+14,071
| New | +$467K | ﹤0.01% | 6672 |
|
|
2017
Q2 | – | Sell |
-25,522
| Closed | -$744K | – | 9827 |
|
|
2017
Q1 | $638K | Buy |
+25,522
| New | +$531K | ﹤0.01% | 6037 |
|
|
2016
Q4 | – | Sell |
-18,578
| Closed | -$316K | – | 10146 |
|
|
2016
Q3 | $340K | Buy |
+18,578
| New | +$326K | ﹤0.01% | 6727 |
|
Other funds holding TDOC
VPM
VCM
VC
Susquehanna International Group's TDOC Position: Q1 2026 in Review
Susquehanna International Group reduced its Teladoc Health (TDOC) stake by 17% in Q1 2026, selling an estimated $987K and leaving 885,526 shares worth $4.83M. The position accounts for ﹤0.01% of the portfolio, ranked #4299.
Susquehanna International Group first reported a position in TDOC in Q3 2016 and has held it in 36 quarters since. The position peaked at $241M in Q1 2021. 323 funds tracked by Wall St. Rank hold TDOC as of Q1 2026.
- Susquehanna International Group held 885,526 shares of Teladoc Health worth $4.83M as of Q1 2026.
- Susquehanna International Group sold 175,942 Teladoc Health shares in Q1 2026, an estimated $987K.
- Teladoc Health made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #4299 holding.
- Susquehanna International Group first reported a position in Teladoc Health in Q3 2016 and has held it in 36 quarters since.
- Susquehanna International Group's Teladoc Health position peaked at $241M in Q1 2021.
- 323 funds tracked by Wall St. Rank held Teladoc Health as of Q1 2026.
Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.